Skip to main content
Top
Published in: Heart and Vessels 1/2012

01-01-2012 | Original Article

Prognostic significance of blood pressure response to exercise in patients with systolic heart failure

Authors: Manolis S. Kallistratos, Leonidas E. Poulimenos, Antonios N. Pavlidis, Athanasios Dritsas, Ioannis D. Laoutaris, Athanasios J. Manolis, Dennis V. Cokkinos

Published in: Heart and Vessels | Issue 1/2012

Login to get access

Abstract

High systolic blood pressure (SBP) has been linked to worse cardiovascular outcomes. However, emerging data suggest that in patients with heart failure (HF), low SBP correlates with increased mortality. The purpose was to examine the impact of baseline and post-exercise systolic and diastolic blood pressure (DBP), as well as pulse pressure (PP), on cardiac mortality in patients with systolic HF. One hundred sixty patients with systolic HF (left ventricular ejection fraction 33 ± 8) were studied. Blood pressure (BP) levels were determined at rest and at peak exercise during a cardiopulmonary exercise test. Patients were followed up for a period of 2.5 ± 0.8 years. During this period 22 patients died and 5 subjects underwent heart transplantation. Patients with higher SBP and DBP at rest, and patients with SBP ≥160 mmHg and PP ≥75 mmHg at peak exercise had the most favorable prognosis. There was a fourfold increase in cardiac mortality risk for patients with SBP <160 mmHg at peak exercise (hazard ratio: 3.97, 95% confidence interval: 1.60–9.84) and a threefold increase for patients with PP <75 mmHg at peak exercise (hazard ratio: 2.96, 95% confidence interval: 1.29–6.82). There is an inverse relationship between SBP and cardiac mortality in patients with systolic HF. BP response to exercise could serve as a simple risk stratification model in HF patients.
Literature
1.
go back to reference Jessup M, Brozena S (2010) Elevated troponin T on discharge predicts poor outcome of decompensated heart failure. Heart Vessels 25:217–222CrossRef Jessup M, Brozena S (2010) Elevated troponin T on discharge predicts poor outcome of decompensated heart failure. Heart Vessels 25:217–222CrossRef
2.
go back to reference Darne B, Girerd X, Safar M, Cambien F, Guize L (1989) Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension 13:392–400PubMed Darne B, Girerd X, Safar M, Cambien F, Guize L (1989) Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension 13:392–400PubMed
3.
go back to reference Franklin SS, Khan SA, Wong ND, Larson MG, Levy D (1999) Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study. Circulation 100:354–360PubMed Franklin SS, Khan SA, Wong ND, Larson MG, Levy D (1999) Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study. Circulation 100:354–360PubMed
4.
go back to reference Benetos A, Safar M, Rudnichi A, Smulyan H, Richard JL, Ducimetieere P, Guize L (1997) Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension 30:1410–1415PubMed Benetos A, Safar M, Rudnichi A, Smulyan H, Richard JL, Ducimetieere P, Guize L (1997) Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension 30:1410–1415PubMed
5.
go back to reference Fang J, Madhavan S, Cohen H, Alderman MH (1995) Measures of blood pressure and myocardial infarction in treated hypertensive patients. J Hypertens 13:413–419PubMedCrossRef Fang J, Madhavan S, Cohen H, Alderman MH (1995) Measures of blood pressure and myocardial infarction in treated hypertensive patients. J Hypertens 13:413–419PubMedCrossRef
6.
go back to reference Chae CU, Pfeffer MA, Glynn RJ, Mitchell GF, Taylor JO, Hennekens CH (1999) Increased pulse pressure and risk of heart failure in the elderly. JAMA 281:634–639PubMedCrossRef Chae CU, Pfeffer MA, Glynn RJ, Mitchell GF, Taylor JO, Hennekens CH (1999) Increased pulse pressure and risk of heart failure in the elderly. JAMA 281:634–639PubMedCrossRef
7.
go back to reference Vaccarino V, Holford TR, Krumholz HM (2000) Pulse pressure and risk for myocardial infarction and heart failure in the elderly. J Am Coll Cardiol 36:130–138PubMedCrossRef Vaccarino V, Holford TR, Krumholz HM (2000) Pulse pressure and risk for myocardial infarction and heart failure in the elderly. J Am Coll Cardiol 36:130–138PubMedCrossRef
8.
go back to reference Chrysohoou C, Pitsavos C, Barbetseas J, Kotroyiannis I, Brili S, Vasiliadou K, Papadimitriou L, Stefanadis C (2009) Chronic systemic inflammation accompanies impaired ventricular diastolic function, detected by Doppler imaging, in patients with newly diagnosed systolic heart failure (Hellenic Heart Failure Study). Heart Vessels 24:22–26PubMedCrossRef Chrysohoou C, Pitsavos C, Barbetseas J, Kotroyiannis I, Brili S, Vasiliadou K, Papadimitriou L, Stefanadis C (2009) Chronic systemic inflammation accompanies impaired ventricular diastolic function, detected by Doppler imaging, in patients with newly diagnosed systolic heart failure (Hellenic Heart Failure Study). Heart Vessels 24:22–26PubMedCrossRef
9.
go back to reference Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, van Zwieten PA, Viigimaa M, Zanchetti A (2009) European Society of Hypertension. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 27:2121–2158PubMedCrossRef Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, van Zwieten PA, Viigimaa M, Zanchetti A (2009) European Society of Hypertension. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 27:2121–2158PubMedCrossRef
10.
go back to reference Güder G, Frantz S, Bauersachs J, Allolio B, Wanner C, Koller MT, Ertl G, Angermann CE, Störk S (2009) Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors. Circ Heart Fail 2:563–571PubMedCrossRef Güder G, Frantz S, Bauersachs J, Allolio B, Wanner C, Koller MT, Ertl G, Angermann CE, Störk S (2009) Reverse epidemiology in systolic and nonsystolic heart failure: cumulative prognostic benefit of classical cardiovascular risk factors. Circ Heart Fail 2:563–571PubMedCrossRef
11.
go back to reference Williams SG, Jackson M, Ng LL, Barker D, Patwala A, Tan LB (2005) Exercise duration and peak systolic blood pressure are predictive of mortality in ambulatory patients with mild-moderate chronic heart failure. Cardiology 104:221–226PubMedCrossRef Williams SG, Jackson M, Ng LL, Barker D, Patwala A, Tan LB (2005) Exercise duration and peak systolic blood pressure are predictive of mortality in ambulatory patients with mild-moderate chronic heart failure. Cardiology 104:221–226PubMedCrossRef
12.
go back to reference Lee TT, Chen J, Cohen DJ, Tsao L (2006) The association between blood pressure and mortality in patients with heart failure. Am Heart J 151:76–83PubMedCrossRef Lee TT, Chen J, Cohen DJ, Tsao L (2006) The association between blood pressure and mortality in patients with heart failure. Am Heart J 151:76–83PubMedCrossRef
13.
go back to reference Raphael CE, Whinnett ZI, Davies JE, Fontana M, Ferenczi EA, Manisty CH, Mayet J, Francis DP (2009) Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure. Heart 95:56–62PubMedCrossRef Raphael CE, Whinnett ZI, Davies JE, Fontana M, Ferenczi EA, Manisty CH, Mayet J, Francis DP (2009) Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure. Heart 95:56–62PubMedCrossRef
14.
go back to reference Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV (2008) Incremental value of N-terminal pro-brain natriuretic peptide over left ventricle ejection fraction and aerobic capacity for estimating prognosis in heart failure patients. J Heart Lung Transplant 27:1251–1256PubMedCrossRef Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV (2008) Incremental value of N-terminal pro-brain natriuretic peptide over left ventricle ejection fraction and aerobic capacity for estimating prognosis in heart failure patients. J Heart Lung Transplant 27:1251–1256PubMedCrossRef
15.
go back to reference Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV (2007) N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance. J Heart Lung Transplant 26:516–521PubMedCrossRef Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV (2007) N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance. J Heart Lung Transplant 26:516–521PubMedCrossRef
16.
go back to reference Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR (1991) Value of peak exercise consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83:778–786PubMed Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR (1991) Value of peak exercise consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83:778–786PubMed
17.
go back to reference Riley M, Northridge DB, Henderson E, Stanford CF, Nichols DP, Dargie HJ (1992) The use of an exponential protocol for bicycle and treadmill exercise testing in patients with chronic cardiac failure. Eur Heart J 13:1363–1367PubMed Riley M, Northridge DB, Henderson E, Stanford CF, Nichols DP, Dargie HJ (1992) The use of an exponential protocol for bicycle and treadmill exercise testing in patients with chronic cardiac failure. Eur Heart J 13:1363–1367PubMed
18.
go back to reference Wu A, Smith A, Wieczorek S, Mather J, Duncan B, White C, McGill C (2003) Biological variation for N-terminal Pro and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 92:628–631PubMedCrossRef Wu A, Smith A, Wieczorek S, Mather J, Duncan B, White C, McGill C (2003) Biological variation for N-terminal Pro and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 92:628–631PubMedCrossRef
19.
go back to reference Domanski MJ, Mitchell GF, Norman JE, Exner DV, Pitt B, Pfeffer MA (1999) Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. J Am Coll Cardiol 33:951–958PubMedCrossRef Domanski MJ, Mitchell GF, Norman JE, Exner DV, Pitt B, Pfeffer MA (1999) Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. J Am Coll Cardiol 33:951–958PubMedCrossRef
20.
go back to reference Voors A, Petrie C, Petrie M (2005) Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure. Eur Heart J 26:1759–1764PubMedCrossRef Voors A, Petrie C, Petrie M (2005) Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure. Eur Heart J 26:1759–1764PubMedCrossRef
21.
go back to reference Kostis JB, Davis BR, Cutler J, Grimm RH Jr, Berge KG, Cohen JD, Lacy CR, Perry HM Jr, Blaufox MD, Wassertheil-Smoller S, Black HR, Schron E, Berkson DM, Curb JD, Smith WM, McDonald R, Applegate WB (1997) Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. JAMA 278:212–216PubMedCrossRef Kostis JB, Davis BR, Cutler J, Grimm RH Jr, Berge KG, Cohen JD, Lacy CR, Perry HM Jr, Blaufox MD, Wassertheil-Smoller S, Black HR, Schron E, Berkson DM, Curb JD, Smith WM, McDonald R, Applegate WB (1997) Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. JAMA 278:212–216PubMedCrossRef
22.
go back to reference Weber MA (1987) Cardiovascular outcomes of treating high blood pressure. Am Heart J 114:964–971PubMed Weber MA (1987) Cardiovascular outcomes of treating high blood pressure. Am Heart J 114:964–971PubMed
23.
go back to reference Messerli FH, Mancia G, Conti CR, Hewkin AC, Kupfer S, Champion A, Kolloch R, Benetos A, Pepine CJ (2006) Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 144:884–893PubMed Messerli FH, Mancia G, Conti CR, Hewkin AC, Kupfer S, Champion A, Kolloch R, Benetos A, Pepine CJ (2006) Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 144:884–893PubMed
24.
go back to reference Anand IS, Tam SW, Rector TS, Taylor AL, Sabolinski ML, Archambault WT, Adams KF, Olukotun AY, Worcel M, Cohn JN (2007) Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial. J Am Coll Cardiol 49:32–39PubMedCrossRef Anand IS, Tam SW, Rector TS, Taylor AL, Sabolinski ML, Archambault WT, Adams KF, Olukotun AY, Worcel M, Cohn JN (2007) Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial. J Am Coll Cardiol 49:32–39PubMedCrossRef
25.
go back to reference Jourdain P, Jondeau G, Funck F, Gueffet P, Le Helloco A, Donal E, Aupetit JF, Aumont MC, Galinier M, Eicher JC, Cohen-Solal A, Juillière Y (2007) Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 49:1733–1739PubMedCrossRef Jourdain P, Jondeau G, Funck F, Gueffet P, Le Helloco A, Donal E, Aupetit JF, Aumont MC, Galinier M, Eicher JC, Cohen-Solal A, Juillière Y (2007) Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 49:1733–1739PubMedCrossRef
Metadata
Title
Prognostic significance of blood pressure response to exercise in patients with systolic heart failure
Authors
Manolis S. Kallistratos
Leonidas E. Poulimenos
Antonios N. Pavlidis
Athanasios Dritsas
Ioannis D. Laoutaris
Athanasios J. Manolis
Dennis V. Cokkinos
Publication date
01-01-2012
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 1/2012
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-010-0115-z

Other articles of this Issue 1/2012

Heart and Vessels 1/2012 Go to the issue